Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03608046
Title Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer (AVETUXIRI)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Cliniques universitaires Saint-Luc- Universite Catholique de Louvain
Age Groups: adult | senior
Covered Countries BEL

Additional content available in CKB BOOST